Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Technologies - Radioactive and Nonradioactive Probes: Automation & Technology Development

Multi-pot radiosynthesizer capable of high-pressure reactions for production of [18F]FAC and analogs

Henry Herman, Graciela Flores, Kevin Quinn, Melissa Esterby, Gaurav Shah, Michael Phelps, Nagichettiar Satyamurthy and Michael Van Dam
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1440;
Henry Herman
1Dept. of Molecular & Medical Pharmacology, UCLA Crump Institute for Molecular Imaging, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graciela Flores
1Dept. of Molecular & Medical Pharmacology, UCLA Crump Institute for Molecular Imaging, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Quinn
1Dept. of Molecular & Medical Pharmacology, UCLA Crump Institute for Molecular Imaging, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Esterby
2Sofie Biosciences, Inc., Culver City, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gaurav Shah
2Sofie Biosciences, Inc., Culver City, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Phelps
1Dept. of Molecular & Medical Pharmacology, UCLA Crump Institute for Molecular Imaging, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagichettiar Satyamurthy
1Dept. of Molecular & Medical Pharmacology, UCLA Crump Institute for Molecular Imaging, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Van Dam
1Dept. of Molecular & Medical Pharmacology, UCLA Crump Institute for Molecular Imaging, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1440

Objectives Recently, a family of PET probes based on the fluorinated nucleoside analog 1-(2’-deoxy-2’-[18F]fluoroarabinofuranosyl)cytosine ([18F]FAC) has been developed that measures activity of deoxycytidine kinase (dCK) [1]. The probes show promise for use in oncology as predictors of tumor response to dCK-dependent drugs [2], and in immunology to measure activation of the immune system in response to pathogens or cancer [3]. Research interest is high, but supply of [18F]FAC is limited due to its difficult and lengthy synthesis and lack of a commercial synthesizer for it.

Methods Similar to the 4-step synthesis of [18F]FMAU and analogs pioneered by Mangner et al. [4], the synthesis of [18F]FAC involves highly corrosive and moisture-sensitive reagents and high-pressure reactions to obtain good yields. Attempts to use commercial synthesizers for these syntheses have generally led to low yields due to adverse effects of exposing valves or tubing to high pressures, or due to reduction of reaction temperatures to avoid high pressures [5,6]. We have developed a reactor for our modular, macroscale radiosynthesizer plaform that avoids these issues by using motion actuators to automatically seal reaction vessels with an inert stopper for high-pressure reactions.

Results Our reactor can robustly maintain temperatures up to 200°C and sealed conditions at pressures above 150 psi, sufficient for all steps of the synthesis. Using a first-generation prototype system constructed from 3 of these reactors, we have successfully synthesized [18F]FAC. Based on this proof of concept, additional engineering was carried out in collaboration with Sofie Biosciences to develop a commercial prototype.

Conclusions This prototype addresses limitations of available synthesizers for successful synthesis of [18F]FAC. It could be used for the routine, semi-automated production of cGMP-compliant [18F]FAC for use in preclinical and clinical environments

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multi-pot radiosynthesizer capable of high-pressure reactions for production of [18F]FAC and analogs
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Multi-pot radiosynthesizer capable of high-pressure reactions for production of [18F]FAC and analogs
Henry Herman, Graciela Flores, Kevin Quinn, Melissa Esterby, Gaurav Shah, Michael Phelps, Nagichettiar Satyamurthy, Michael Van Dam
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1440;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Multi-pot radiosynthesizer capable of high-pressure reactions for production of [18F]FAC and analogs
Henry Herman, Graciela Flores, Kevin Quinn, Melissa Esterby, Gaurav Shah, Michael Phelps, Nagichettiar Satyamurthy, Michael Van Dam
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1440;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Automation & Technology Development

  • Microwave-assisted one-pot radiosynthesis of 2’-deoxy-2’-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU)
  • Synthesis of an 18F-labeled CP18 peptide as a potential apoptosis biomarker in PET imaging
  • Production of the alpha particle emitting radionuclide At-211 at the Texas A&M Cyclotron Institute
Show more Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Automation & Technology Development

Automation & Technology Development Posters

  • Microwave-assisted one-pot radiosynthesis of 2’-deoxy-2’-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU)
  • Synthesis of an 18F-labeled CP18 peptide as a potential apoptosis biomarker in PET imaging
  • Production of the alpha particle emitting radionuclide At-211 at the Texas A&M Cyclotron Institute
Show more Automation & Technology Development Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire